FAQ

The Tide is a peptide-focused medical clinic in Houston, Texas, located adjacent to the Texas Medical Center at 6909 Grand Boulevard. We specialize in peptide therapy, hormone optimization, medical weight loss, recovery and regenerative medicine, sexual wellness, immune and inflammation care, longevity protocols, NAD+ and IV therapy, and advanced lab testing. Unlike medspas that offer peptides as one of many services, peptides and related medicine are our entire focus.

We don’t offer injectables, facials, laser treatments, or any of the other services medspas typically bundle with peptide therapy. Peptides and related medicine are the only thing we do. That changes what our physicians train for, how we staff the clinic, how we source our peptides, and how much time we spend on patient education.

It also changes what we’ll tell you. Because we aren’t trying to upsell you on a facial when peptides aren’t the right answer, we can be honest when they aren’t.

Our clinic is at 6909 Grand Boulevard, Houston, Texas 77054 — adjacent to the Texas Medical Center. We’re accessible from across the Houston metro including the Museum District, Bellaire, Rice Village, the Heights, West University, Galleria, River Oaks, Memorial, and the broader TMC area. Free parking is available on site.

We offer peptide therapy as our specialty service, plus medical weight loss with GLP-1 medications (semaglutide, tirzepatide), men’s hormone health (TRT), women’s hormone health (HRT and menopause care), recovery and regenerative medicine (BPC-157, TB-500, GHK-Cu), longevity and performance (sermorelin, CJC-1295, ipamorelin, MOTS-c), sexual wellness (PT-141, oxytocin), immune and inflammation care (LDN, thymosin alpha-1, KPV), NAD+ and IV therapy, and advanced lab testing with genetic analysis. Each service has its own dedicated page with the specifics.

No. Anabolic steroids are modified testosterone molecules with specific anabolic and androgenic effects. Peptides are short chains of amino acids that act as signaling molecules at specific receptors. They are a completely different drug class with different mechanisms, different effects, and different safety profiles.

Peptide therapy addresses a wide range of clinical goals depending on the specific peptide. GLP-1 peptides like semaglutide and tirzepatide treat metabolic disease and obesity. Growth hormone secretagogues like sermorelin and ipamorelin support age-related GH-axis decline. BPC-157 and TB-500 support tissue recovery and regeneration. PT-141 addresses sexual desire and arousal. Thymosin alpha-1 and KPV modulate immune function. The right peptide depends on what you’re trying to treat — which is the work of consultation, not a script you fill from a website.

It depends on what you’re trying to do and what the evidence supports for that goal. For some goals — weight management with GLP-1 agonists, for example — the evidence is strong and response rates are high. For others, the evidence is thinner and results are more variable.

A consultation is the only way to give you a real answer, because the answer depends on your specific case.

No — and honestly, we prefer patients who don’t. Our approach is to start with your goal, not a peptide name. If you arrive asking for a specific peptide, that’s fine; we’ll still work through whether it’s the right one for your situation.

Our patients tend to be Houston professionals in their 30s through 60s who are serious about their health and want a clinic that thinks like they do. Many are seeking medical weight loss with GLP-1 therapy. Many are addressing hormone changes — perimenopause, menopause, low testosterone, andropause. Many are athletes or active people working through recovery from injury. Some are pursuing longevity and optimization. Some are managing complex conditions like autoimmune disease or long COVID. What unites them: they want evidence-based medicine, not aspirational marketing.

It means our clinical practice is built around peptide therapy as the primary specialty, not added to a generalist practice. Our physicians focus on this work. Our protocols are built around it. Our lab panels are designed for it. Our partner pharmacies are selected for it. Our editorial library is the deepest publicly available peptide resource of any Houston clinic. When you come to The Tide, you’re seeing clinicians who do this work all day, not clinicians who fit it around fifteen-minute appointments.

Yes. Medical weight loss with GLP-1 therapy is one of our core services. We prescribe semaglutide (the active ingredient in Ozempic, Wegovy, and Rybelsus) and tirzepatide (the active ingredient in Mounjaro and Zepbound) in both branded and compounded forms when clinically appropriate. Our medical weight loss program includes baseline labs, physician consultation, supervised titration, and ongoing monitoring. See our Medical Weight Loss page for the full picture.

Yes. We offer comprehensive TRT for men with documented low testosterone, including testosterone cypionate or enanthate injections, gonadorelin or HCG for fertility preservation, and aromatase inhibitors when clinically indicated. Our approach emphasizes proper baseline workup, fertility-aware protocols for men who may want children in the future, and structured monitoring — not the transactional “low-T clinic” pattern. See our Men’s Hormone Health page.

Yes. We offer comprehensive HRT for women in perimenopause, menopause, and post-menopause, using bioidentical estradiol, micronized progesterone, and testosterone for women when appropriate. We also work with women on hormonal optimization in earlier life stages. See our Women’s Hormone Health page for details on our approach to menopause care, perimenopause management, and bioidentical hormone therapy.

Yes. Menopause and perimenopause care is a core part of our Women’s Hormone Health service. We address vasomotor symptoms (hot flashes, night sweats), sleep disruption, mood changes, libido, vaginal symptoms, and bone health. We use bioidentical estradiol and micronized progesterone in evidence-based protocols, and we discuss the WHI re-analyses and modern menopausal hormone therapy evidence honestly with patients. Houston has limited high-quality menopause care, and we built this service to fill that gap.

Yes. LDN is a primary medication in our Immune & Inflammation service. We prescribe LDN for fibromyalgia, Hashimoto’s thyroiditis, IBD, multiple sclerosis (with neurology coordination), chronic fatigue syndrome, long COVID, and other inflammatory conditions. We use standard titration protocols, monitor response carefully, and coordinate with your specialty care. Our Resources article on LDN goes deeper into the mechanism, evidence by condition, and what to realistically expect.

Yes. Long COVID care is part of our Immune & Inflammation service. We approach long COVID as legitimate medical territory rather than dismissing it. Our toolkit for post-viral syndrome patients includes Low Dose Naltrexone (which has reasonable evidence for long COVID), thymosin alpha-1, NAD+ therapy, and other supportive interventions. We will not promise miracle outcomes — the evidence base is still developing — but we will engage seriously with the condition and coordinate with your other providers.

Yes, in many cases. Low Dose Naltrexone has reasonable RCT evidence for fibromyalgia with effect sizes comparable to or better than common fibromyalgia medications. We also work with peptide adjuncts like BPC-157 for related musculoskeletal concerns. We are not a primary pain management practice and do not prescribe controlled substances; for patients on chronic opioid therapy, LDN cannot be used until they have transitioned off opioids under their pain management physician’s care.

Yes. We offer NAD+ infusions and NAD+ injection protocols for energy support, longevity protocols, recovery, and post-viral syndromes. NAD+ IV therapy is delivered in our clinic with proper medical oversight. We are not a “drip lounge” — our IV protocols are clinical and structured, with appropriate monitoring during infusion.

Yes. Sexual Wellness is a dedicated service. We address erectile dysfunction with PDE5 inhibitors and hormone optimization, low libido in both men and women with peptides like PT-141 (bremelanotide) and oxytocin, and broader sexual function concerns with appropriate workup. We treat sexual wellness as legitimate medicine rather than as a transactional script — meaning we look for underlying causes (hormonal, vascular, psychological, medication-related) and address them where possible, not just write prescriptions.

Yes. Recovery & Regenerative is a dedicated service. We work with peptides like BPC-157, TB-500, thymosin beta-4, and GHK-Cu for tendinopathy, post-surgical recovery, soft-tissue injuries, and chronic musculoskeletal concerns. Many of our patients are active people in their 30s through 60s working through specific injuries or chronic recovery issues. We coordinate with orthopedic surgeons and sports medicine physicians when appropriate.

Yes, but we approach longevity as evidence-based medicine rather than aspirational marketing. Our Longevity & Performance service includes growth hormone secretagogues like sermorelin and CJC-1295/ipamorelin for age-related GH-axis decline, MOTS-c for mitochondrial support, hormone optimization where appropriate, and structured biomarker tracking. We do not promise to reverse aging. We do offer the most evidence-supported tools available within current medicine.

Yes. Advanced Labs & Genetics is a dedicated service. We offer comprehensive lab panels well beyond standard primary care — including detailed hormone panels, advanced lipid markers, inflammatory markers, micronutrient testing, and where clinically appropriate, genetic testing for medication metabolism, cardiovascular risk, and methylation pathways. The labs are interpreted clinically with you, not just emailed as a PDF.

Yes, as part of our Immune & Inflammation service. For Hashimoto’s specifically, we work with patients on LDN (which has accumulating evidence for reducing thyroid antibodies and improving well-being), thyroid hormone optimization in coordination with their existing physician, and addressing root contributors to autoimmune flares. We coordinate with your endocrinologist or primary care physician on thyroid hormone replacement.

We offer adjunctive support for IBD patients alongside their gastroenterology care. LDN has small RCT evidence and substantial clinical experience as adjunctive therapy in Crohn’s and ulcerative colitis. BPC-157 has theoretical and accumulating clinical support for gut barrier function and inflammation. We do not replace appropriate gastroenterology management of IBD, and we coordinate with your specialist.

“Safe” is a useful word only in context. FDA-approved peptides have well-characterized safety profiles from clinical trials. Compounded peptides in the established formulary have years to decades of clinical experience and generally favorable safety records.

The risk profile depends on which peptide, at what dose, in what patient, for what duration, and — critically — from what source. Underground-sourced peptides from research-chemical vendors carry meaningful risk of contamination, misdosing, and infection. We don’t work with those.

It varies widely by peptide. GLP-1 agonists commonly cause GI side effects, especially during titration. Growth hormone secretagogues can cause water retention, joint discomfort, and blood sugar changes. PT-141 can cause nausea, flushing, and transient blood pressure changes. BPC-157 is generally well-tolerated in available data. LDN can cause vivid dreams in the first weeks. Specific side effects are reviewed during consultation for any peptide we recommend.

Often, yes — but this is exactly what the physician review is for. Some peptides interact meaningfully with cardiovascular medications, diabetes medications, psychiatric medications, and thyroid replacement. We review your full medication list before prescribing anything.

Yes. We don’t prescribe to patients with active malignancy in most cases, during pregnancy or breastfeeding, to patients who decline basic lab work or follow-up, or to patients who are concurrently using underground-sourced peptides. We also won’t prescribe peptides outside their evidence base simply because the patient wants them.

It depends on the peptide and the cancer history. Some peptides — particularly growth hormone secretagogues and certain regenerative peptides — are contraindicated in patients with active cancer or recent cancer history because they could theoretically promote cell proliferation. Other peptides (GLP-1s in some contexts, immune-modulating peptides in others) may be appropriate or even beneficial. This is a case-by-case decision made during consultation with your full history.

No. We do not prescribe peptides during pregnancy or breastfeeding because the safety data is insufficient. Patients who become pregnant on therapy should pause treatment and contact us. We do prescribe to women who are planning pregnancy, with adjustments to protocols and timing.

The safety profiles are different in important ways. FDA-approved peptides go through formal clinical trials with characterized safety endpoints. Compounded peptides have safety profiles supported by accumulated clinical experience and preclinical data, but with more variability between compounding pharmacies. We work only with licensed compounding pharmacies that meet specific quality standards (primarily 503B outsourcing facilities for many peptides), which substantially reduces the variability concern. We discuss compounding considerations openly with patients.

Stop the medication and contact our clinical team immediately. Most reactions to peptides we prescribe are mild and self-limited (GI symptoms during GLP-1 titration, vivid dreams when starting LDN, mild injection-site reactions). Severe reactions are rare. We have protocols for managing significant adverse events and we are reachable through our patient portal during business hours and through after-hours channels for urgent issues.

Yes, when relevant. Several peptides require cardiovascular consideration. PT-141 can transiently affect blood pressure. Some growth hormone protocols affect glucose metabolism and may require monitoring in patients with cardiovascular risk factors. TRT requires baseline lipid evaluation and ongoing monitoring. Our baseline workup captures the relevant cardiovascular markers, and we adjust protocols accordingly.

Typically two to three weeks from consultation to first dose. That includes intake, lab work (if not already current), physician protocol design, and dispensing through the pharmacy. Some programs move faster when recent labs are available; some take longer when additional workup is needed.

The first consultation requires an in-person visit at our Houston office (6909 Grand Boulevard, adjacent to the Texas Medical Center). After we have established care and completed your baseline workup, follow-up visits and prescription refills can often be handled via telehealth for established patients in Texas and select other states where our physicians are licensed.

Our physicians are licensed in Texas as the primary state of practice, and a small number of additional states for follow-up telehealth care of established patients. State medical licensing rules limit telehealth to states where the prescribing physician is licensed. If you’re outside Texas and considering telehealth follow-up after an initial in-person visit, contact us first to confirm coverage in your state.

The initial visit is 45 minutes. We discuss your goals, review your medical history, walk through any current symptoms or concerns, and decide together what workup is appropriate. We will not prescribe in the first visit. Prescription decisions follow your baseline labs and a clinical decision. The consultation is the start of an evaluation, not the prescription itself.

The lab panel depends on what we’re evaluating. A typical baseline includes a comprehensive metabolic panel, complete blood count, lipid panel with advanced markers, hemoglobin A1c, fasting insulin, and inflammatory markers (hsCRP). Hormone-related visits add full hormone panels with appropriate sensitivities. GH-related visits add IGF-1 and IGFBP-3. Immune visits add ANA, autoimmune markers, vitamin D, and condition-specific markers. Most labs are done at LabCorp or Quest near you.

You’ll have structured check-ins with your physician on a schedule appropriate to your program — typically at 6 to 12 weeks after starting, then quarterly for stable patients. Between visits, you can message the clinical team through our patient portal. Labs are repeated at defined intervals, and your protocol is adjusted based on how your body responds.

Peptides are dispensed through licensed compounding pharmacies. Most are shipped directly to your home in temperature-controlled packaging. Some FDA-approved medications can also be filled at retail pharmacies. We discuss the dispensing pathway during consultation and you’ll know exactly where your medications are coming from.

It depends on the protocol. For most peptide protocols, we repeat relevant labs at 90 days after starting and every 6 months thereafter. Hormone optimization protocols typically require lab checks at 6 weeks and 3 months during dose-finding, then every 6 months once stable. Some specific situations require more frequent checks.

Yes. No program locks you in. Some peptides have specific tapering considerations we’ll walk you through, but the decision to continue or stop is always yours.

Yes. Established patients communicate with the clinical team through our HIPAA-compliant patient portal. The portal handles secure messaging, lab result review, prescription requests, and visit scheduling. We do not handle clinical questions through email or our website contact forms — those channels are not appropriate for protected health information.

For medical emergencies, call 911. For urgent clinical questions during business hours, message us through the patient portal — we monitor it actively. After-hours urgent clinical issues for established patients are handled through our on-call line, the number for which is provided to active patients. Our website contact form is for general inquiries only, not urgent clinical questions.

Yes. FDA-approved peptides are prescribed like any other FDA-approved medication. Compounded peptides are dispensed through licensed 503A and 503B compounding pharmacies under specific regulations. Both pathways are legal, regulated, and routine in medicine — compounding has existed long before peptides.

Research-chemical peptides sold online are a different category, and not one we participate in.

503A pharmacies compound medications for specific patients based on a prescription. 503B pharmacies (outsourcing facilities) can compound larger batches under stricter FDA oversight. Both are legitimate; the choice depends on the specific peptide and regulatory pathway.

Our sourcing uses vetted pharmacies of both types. Our Standards page covers this in more detail.

Yes. FDA guidance on certain compounded peptides has evolved over the last few years, with specific peptides being added to or removed from the lists permitted for compounding. We track these changes continuously and adjust our formulary to stay within the current regulatory framework.

No. Research peptides sold online with “for research purposes only” disclaimers are not legally available for human use, are not pharmaceutical-grade, and carry meaningful risk of contamination, misdosing, and infection. We work exclusively with FDA-approved pharmaceuticals and licensed compounding pharmacies. Patients currently using research peptides are encouraged to stop and consult with us about pharmaceutical-grade alternatives.

FDA-approved branded medications (Wegovy, Ozempic, Mounjaro, Zepbound) are mass-manufactured drug products with full Phase III evidence. Compounded versions of semaglutide and tirzepatide are prepared by licensed compounding pharmacies. The FDA has stated that compounded versions are generally not appropriate when the FDA-approved version is not in shortage. Our default is the FDA-approved product when available; compounded versions are used when clinically justified and consistent with current regulatory framework.

We prioritize 503B outsourcing facilities (FDA-registered, cGMP standards) when they offer the medication needed. For patient-specific compounding, we use 503A pharmacies with documented quality systems, third-party testing, and clean regulatory histories. We can name the pharmacy filling your prescription and explain why we chose them.

The initial consultation is $195. Programs range from roughly $449 to $875 per month depending on the peptide, the monitoring required, and the program structure. Our Programs page has specific starting prices for each offering.

We are transparent about pricing before you enroll. There are no hidden fees, no auto-renewals without consent, and no prescription charges on top of the program cost.

Most peptide therapy is not covered by insurance, because most peptides we prescribe are either compounded (not typically covered) or prescribed off-label (often not covered). For FDA-approved peptides being used on-label — like semaglutide for Type 2 diabetes — we can provide documentation to support your own insurance submission, but we don’t bill insurers directly.

Some patients use HSA/FSA funds for consultations and certain program costs; check with your plan.

Programs are billed month-to-month or per cycle, depending on structure. You can stop at any time. We don’t use long-term contracts or multi-month prepayment requirements.

For most consultations and many medications, yes. HSA and FSA funds typically cover physician consultations, medical labs, and prescription medications. Some compounded medications and some optional services may not qualify; check with your plan administrator. We can provide receipts and documentation suitable for HSA/FSA submission.

Costs vary by medication and dose. FDA-approved branded medications (Wegovy, Mounjaro, Zepbound) typically cost $1,000 to $1,400 per month at retail without insurance, though manufacturer savings programs can substantially reduce this. Compounded semaglutide and tirzepatide, when appropriate and consistent with current regulatory framework, are typically more accessible. Our medical weight loss program fee covers the consultation, monitoring, and clinical oversight; medication costs are separate. We discuss specific costs during consultation.

TRT pricing depends on the protocol. Testosterone cypionate or enanthate injections are inexpensive (often under $50/month at retail). Adjunctive medications (gonadorelin, HCG, anastrozole) add modest additional cost. Our hormone health program fee covers the consultation, lab review, and ongoing monitoring; medication costs are separate. Total monthly cost for most TRT protocols at The Tide is in the $250 to $400 per month range including all clinical services.

LDN itself is inexpensive — typically under $50 per month at most compounding pharmacies. The clinical service fees for our Immune & Inflammation program cover consultation, lab review, and ongoing monitoring; the LDN medication cost is separate and modest.

For larger upfront workups (initial labs plus consultation), we can sometimes split the cost across multiple billing cycles. We do not offer financing for ongoing program costs — programs are billed month-to-month, so you can pause or stop if cost becomes a concern.

Yes, when clinically appropriate. GLP-1 and dual agonists are a cornerstone of our metabolic program. We consider medical history, BMI or metabolic markers, lifestyle factors, and other options before prescribing, and we adjust based on how you tolerate the therapy.

Yes, in specific clinical scenarios — typically targeted recovery from tendinopathy, post-surgical healing, or certain functional gut conditions. We prescribe it as short, defined cycles rather than continuous use, and we discuss the evidence base honestly during consultation.

We prescribe CJC-1295, ipamorelin, sermorelin, and tesamorelin in appropriate cases. These peptides support endogenous growth hormone release rather than replacing it exogenously. We monitor IGF-1 throughout, and we don’t market them as anti-aging therapy.

Yes. PT-141 is an FDA-approved medication (under the brand name Vyleesi) for hypoactive sexual desire disorder in pre-menopausal women, and used off-label in men and post-menopausal women for similar concerns. We prescribe it when appropriate and discuss the realistic expectations — PT-141 affects desire and arousal but is not a treatment for erectile dysfunction specifically.

Yes, in appropriate clinical scenarios — primarily for soft tissue recovery, persistent musculoskeletal injuries, and certain regenerative protocols. As with BPC-157, we use defined cycles rather than continuous therapy and discuss the evidence base openly.

Yes. We offer both NAD+ subcutaneous injection protocols (which patients self-administer) and NAD+ IV infusions in our clinic. The choice depends on goals, tolerance, and the specific protocol.

Oxytocin can be appropriate for selected patients addressing intimacy, attachment, or arousal concerns where hormonal contributors play a role. We discuss the modest evidence base honestly and use it as part of broader sexual wellness work, not as a standalone “love hormone” treatment.

MOTS-c is a mitochondrial-derived peptide we use in selected longevity and metabolic protocols. The evidence base is preclinical and early-clinical, which we discuss honestly. It is not a primary therapy for most patients but can be appropriate for specific situations.

AOD-9604 is a fragment peptide we work with in selected metabolic and recovery protocols. The evidence is more limited than for many of our primary peptides; we use it judiciously and discuss the realistic effect size with patients.

We do not prescribe Melanotan II. Its broad melanocortin activity has documented associations with atypical pigmented lesions and possible melanoma risk. For sexual desire concerns specifically, we use bremelanotide (PT-141), which is the FDA-approved selective melanocortin agonist with a substantially better safety profile.

The Peptide Library lists the peptides we actively work with. If you’ve read about a peptide not in the library, it’s either because we don’t consider the human evidence sufficient to prescribe, because it falls outside the current compounding pathway, or because it’s outside our scope of practice. We’re happy to discuss specific peptides on a consultation.

No. We work exclusively with FDA-approved pharmaceuticals and licensed compounding pharmacies that meet specific quality standards. Research-only compounds purchased from research peptide vendors do not meet pharmaceutical quality standards and we cannot incorporate them into clinical care responsibly.

TRT clinics specialize in testosterone replacement and add peptides as an adjunct. The Tide specializes in peptides as the primary work — testosterone is one tool we use, alongside many others. The expertise concentration is different. Patients who need both TRT and broader peptide support are often better served by a peptide-focused practice that handles TRT well than by a TRT practice that handles peptides as a secondary service.

Functional medicine practices typically address a wide range of chronic illness through nutrition, supplementation, lifestyle, and selective use of medications. The Tide is more focused: we are a peptide and pharmaceutical-medicine practice that approaches things with the rigor of conventional medicine and the willingness to use off-label and compounded therapies that traditional primary care often won’t. Some functional medicine work overlaps with what we do (lab interpretation, root-cause thinking); we differ in our depth on peptide pharmacology and our pharmaceutical-first approach to clinical decisions.

Longevity clinics often focus broadly on aging optimization with extensive supplementation, advanced diagnostics, and aspirational marketing. The Tide focuses on the medications and peptides themselves — we offer longevity and performance services, but we don’t promise to extend lifespan or reverse aging. We use the most evidence-supported tools available within current medicine, and we are honest about the limits.

Telehealth-only peptide platforms (Hone, Marek, others) operate at scale with brief consultations, often without in-person visits, often with limited specialty depth. The Tide operates as a real medical practice with in-person initial consultations at our Houston clinic, longer consultation times, and more clinical depth. Telehealth-only platforms work well for some patients with straightforward needs; The Tide is a better fit for patients with complex situations or who want a more involved clinical relationship.

It depends. For routine adult preventive care, you should have a primary care doctor regardless of whether you work with us. For peptide therapy specifically, your primary care doctor is unlikely to have specialized expertise in peptide pharmacology — this is what we focus on. Many of our patients have us as their peptide clinic and a separate primary care relationship for general health, which we coordinate with as relevant.

Often yes, sometimes with specific considerations. Patients with autoimmune disease, cardiovascular history, prior cancer, complex medication regimens, or other significant medical history are welcome — we just need the full picture during consultation so we can make appropriate decisions. Some conditions limit which peptides are appropriate; our job is to figure out what’s available given your specific situation.

Timeline varies substantially by peptide and indication. GLP-1 medications produce noticeable appetite changes within the first week and meaningful weight loss over months. PT-141 produces effects within 30 to 60 minutes of dosing for sexual desire. BPC-157 for tendinopathy typically shows response by week 3 to 4. GH-axis support shows IGF-1 changes over 8 to 12 weeks. LDN typically requires 6 to 12 weeks at therapeutic dose. We discuss expected timelines for your specific protocol during consultation.

Average weight loss in clinical trials of semaglutide is approximately 15 percent of body weight at one year of therapy at therapeutic dose. Tirzepatide produces approximately 20 percent average weight loss at one year. Individual results vary widely — some patients lose substantially more, others less. Long-term outcomes depend heavily on whether you maintain the medication, build sustainable lifestyle changes during treatment, and have appropriate medical oversight. We are honest about realistic expectations during consultation.

Then we stop them. We are not interested in continuing therapy that isn’t producing benefit. If a peptide isn’t working at the expected timeline, we reassess: was the dose adequate, was there a confounding factor, would a different peptide be more appropriate, or is peptide therapy simply not the right intervention for your situation? We will tell you honestly when we think continued treatment isn’t worth it.

It depends on what we’re treating. Some indications (tendinopathy, post-surgical recovery) involve discrete cycles of 4 to 8 weeks. Some indications (GH-axis support, hormone optimization, GLP-1 weight maintenance) involve longer-term therapy that may continue for years. Some treatments (PT-141, PDE5 inhibitors) are used as-needed rather than continuously. We discuss expected duration during consultation and reassess at follow-ups.

It depends on the peptide and what changes were made during therapy. Tendinopathy resolved with BPC-157 typically stays resolved if the underlying causes were addressed. Weight loss with GLP-1 medications often partially regresses without the medication unless substantial lifestyle changes were established during therapy. Hormone optimization effects fade once hormone replacement stops. We discuss durability of effects honestly during consultation.

Strongly yes. Peptides amplify good biology — they do not replace it. A patient sleeping 5 hours nightly, eating poorly, and chronically stressed will get worse outcomes from peptide therapy than a patient with foundational work in place. We discuss foundations honestly during consultation and integrate them into program structure where relevant.

Houston has the largest medical complex in the world (the Texas Medical Center), a sophisticated patient population, and substantial demand for the kind of evidence-based peptide medicine that has been under-served by conventional Houston-area practices. Many Houston patients seeking peptide therapy have been forced to choose between medspa-style practices and out-of-state telehealth platforms; we built The Tide to fill that gap with clinic-grade medical care.

We are located adjacent to the Texas Medical Center at 6909 Grand Boulevard, but we are an independent medical practice. We are not affiliated with Houston Methodist, MD Anderson, Texas Children’s, or any TMC institution. Our proximity to TMC matters for patient access (most TMC-area patients can walk to us) and for coordination with TMC specialists when our patients also see them.

Yes. Patients across Texas and select other states see us. Many patients travel to Houston for the initial in-person consultation and then continue through telehealth follow-ups. Our location adjacent to TMC makes air travel from elsewhere in Texas straightforward (Hobby Airport is 15 minutes away). We can refer to LabCorp or Quest locations near you for ongoing lab work.

Our patients come from across the Houston metro. Frequent neighborhoods include the Texas Medical Center area, Museum District, Bellaire, Rice Village, the Heights, West University, Galleria, River Oaks, Memorial, Montrose, Midtown, and Sugar Land. Many also come from the surrounding Houston suburbs and from elsewhere in Texas.

Yes. Free parking is available on site at 6909 Grand Boulevard. Our location is also accessible from major Houston arteries (Holcombe, Main, Fannin) and is a short drive from most central Houston neighborhoods.

The clinic is open Monday through Friday from 9:00 AM to 5:00 PM Central Time. Telehealth follow-ups for established patients can sometimes be scheduled outside these hours. The patient portal is available 24/7 for established patients to send messages to the clinical team.

No. We work with licensed compounding pharmacies and standard retail pharmacies that fill prescriptions and ship directly to you (or to your local pharmacy for retail medications). This allows us to focus our clinical resources on the medical work rather than running a pharmacy.

Book a consultation through our website. We’ll confirm scheduling within one business day. The first visit is 45 minutes — the right place to discuss whether our care is a fit for your situation. We will not prescribe in the first visit. Prescription decisions follow your baseline labs and a clinical decision after the consultation.

If you have recent labs (within the past 6 months), bring them or send them in advance through the patient portal once you’re scheduled. Have a list of your current medications and supplements. Have a clear sense of what brought you in — what you’re trying to address, what you’ve already tried, and what realistic outcome you’re hoping for. We do the rest during the consultation.

No. We don’t require referrals. Patients self-refer to us directly through the website or by calling the clinic.

Yes, if you’d like. Many patients find it helpful to have a partner present, especially when discussing hormone changes, sexual wellness, or major lifestyle changes. Just let us know during scheduling.

That’s a fine reason to book a consultation. We see many patients who are evaluating whether peptide therapy is a fit before committing. The consultation itself is a service — you’ll leave with a clearer picture of what your options are, what evidence supports them, and what reasonable next steps look like, regardless of whether you proceed with us.